(Q34194044)
Statements
1 reference
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer (English)
1 reference
D Ross Camidge
Robert C Doebele
Marc S Ballas
Thierry Jahan
David Hoffman
Howard West
Pablo Lee
Ling Yang
Adarsh Joshi
Ling Gao
Sergey Yurasov
1 October 2014
1 reference
1 reference
1 reference